BiodefenseStocks.com Reports on Today's Technology and Countermeasures Working to Defend against Biowarfare and Bioterrorism
Homeland Security Department Elevates Bioterrorism to Higher Level of Priority
POINT ROBERTS, WA.; July 20, 2005 - www.BiodefenseStocks.com (BS), and www.HomelandDefenseStocks.com (HDS), investor news portals for the Biodefense and Homeland Security sectors, report on today's technology and countermeasures working to defend against threats of bioterrorism through an exclusive article – "Countermeasures against Bioterrorism and Biowarfare – Are We Prepared?" Companies participating in the nation's biodefense efforts include CryoPort (OTC.PK: CYRX), a manufacturer of a disposable cryogenic shipper for infectious materials; Hollis-Eden Pharmaceuticals, Inc. (NASDAQ: HEPH), developer of the drug Neumune™ for treatment of Acute Radiation Syndrome (ARS); Aethlon Medical (OTCBB: AEMD), a developer of viral filtration devices that rapidly reduce the presence of infectious disease and toxins in the body; Roaming Messenger (OTCBB: RMSG) an interactive messaging solution provider that enables the delivery of critical information; and MDM Group (OTC.PK: MDDM), a developer of vaccines and screening solutions through their Biodefense Division.

BiodefenseStocks.com and HomelandDefenseStocks.com are investor and industry news portals for the biodefense and homeland security sector. The BS and HDS websites do not make recommendations, but offer unique free information portals to research news, exclusive articles, interviews, investor conferences and a growing list of participating public companies in these sectors.
Report Excerpt: Countermeasures against Bioterrorism and Biowarfare – Are We Prepared?
By Ann-Marie Fleming, www.BiodefenseStocks.com and www.HomelandDefenseStocks.com
July 2005

As the Homeland Security Department increases the priority level placed on bioterrorism, and the government pushes forward in the development of Project BioShield, the necessity for evolved and adaptive technology and methods to prevent and resolve such threats, becomes a major focus for National Security and the industry at large.
Security Secretary Michael Chertoff recently presented the results of the Department of Homeland Security's Second Stage Review, which consists of an evaluation of the Department's operations, policies and structures. Subsequent to the release of the results of this review, a renewed sense of priority regarding the nation's ability to detect biological attacks became apparent. As Chertoff states, "we must also prepare for terror attacks of even greater consequence -- attacking transit systems with biological, radiological or chemical agents. We now have in place a network of bio-sensors, but we will accelerate the development and deployment of the next generation technology in bio-sensors to more quickly detect biological, radiological, and chemical attacks."
According to a report by Civitas Group, "In terms of the severity of consequences, the threat of a terrorist attack against the homeland involving a nuclear or biological weapon is the most worrisome scenario facing the United States today." With that said, the report revealed that the biological sensor market is still fairly undeveloped, but is experiencing significant forward progression as a result of the government's focus on such technology and biological threats. According to Mark Shaheen, a Principal at the Civitas Group, "The Second Stage Review indicates the intention of the Department to take a more significant role in biodefense, as evidenced by Chertoff's creation of a Chief Medical Officer who will be a direct, more senior official with responsibility for biodefense issues at the department; this is a positive sign."

Government programs such as Project Bioshield that was implemented to help spark participation in biodefense from the private sector, and in particular from biotechnology and pharmaceutical companies, has further emphasized the prioritization of the threat level associated with bioterrorism. However, Mr. Shaheen explains, while there is significant market potential for biosensors, the impact of BioShield is yet to be fully determined.

To Read the Full Report Click Here: http://www.BiodefenseStocks.com/BDS/News/Bioterror_Defense.asp

Participating Public Companies:
Hollis-Eden Pharmaceuticals, Inc. (NASDAQ: HEPH), Aethlon Medical (OTCBB: AEMD), MDM Group (OTC.PK: MDDM), CryoPort (OTC.PK: CYRX), Roaming Messenger (OTCBB: RMSG)

(HDS and BS are compensated for Featured companies on portals - see disclaimer for details)

BiodefenseStocks.com includes public companies in the sector and industry information on Bioterrorism, Agriterrorism, Vaccines, Countermeasures to Bioterrorism, Biological & Chemical Detection, Emergency Response and Preparedness, Biological, Chemical, and Radiological News.
For a partial list of companies involved in Biodefense Click Here: http://www.biodefensestocks.com/BDS/Stock_List.asp
HomelandDefenseStocks.com includes a growing list of public companies in the sector. Click here for a partial list of companies involved in homeland defense and security technology and solutions in Airport Security, Biodefense, Biometrics, Defense, Internet Security, Integrated Security, Military, Border and Port Security.
http://www.HomelandDefenseStocks.com/Companies/HomelandDefense/Stock_List.asp
Additional HDS Homeland Security Web Sites:

www.NationalHomelandSecurityKnowledgebase.com: including comprehensive Homeland Security information resources, Homeland Security news, Homeland Security marketplace, directories and a collection of links on Homeland Security related topics.
www.BorderAndPortSecurity.com
www.NonlethalStocks.com

The Insiders Corner with Michael Brush
Read the exclusive InvestorIdeas.com Feature "The Insiders Corner," a weekly feature by well-known financial writer and author Michael Brush. http://investorideas.com/insiderscorner/

Investor Incite Newsletter
InvestorIdeas.com free "Investor Incite" Newsletter consists of company and industry updates, investment research and developing trends in key areas such as Homeland Security, Renewable Energy, Nanotechnology and more.
TO SIGN UP, click here: www.InvestorIdeas.com/Resources/Newsletter.asp

Disclaimer: ECON Investor Relations Inc is the owner of the domains www.BiodefenseStocks.com and www.HomelandDefenseStocks.com. Our site does not make recommendations, but offers a unique information portal to investors to research news, articles, and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell any specific products or securities. All investments involve risk. Although we attempt to research thoroughly, we offer no guarantees as to the accuracy of any information presented. We encourage all investors to use our sites only as a resource to further their own research. All information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of ECON or its related web sites. The site is currently compensated for by its "featured companies." CryoPort, Inc.: Five Thousand Dollars per month. Aethlon Medical, Inc.: Three Thousand Dollars per month plus restricted shares equivalent to Five Thousand Dollars per month. MDM Group, Inc. pay an amount equal to approximately thirteen thousand five hundred. MDM Group Inc. shares per month for consulting services provide for both MDM Group Inc. and its subsidiary, Harrington Group Ltd. (HGR). Roaming Messenger, Inc. (OTCBB: RMSG) Three thousand dollars per month, plus three thousand dollars per month equivalent in shares. Featured Companies on HDS / BS current list of stocks. www.InvestorIdeas.com/About/Disclaimer.asp

Contact:

Dawn Van Zant / Trevor Ruehs
Toll free: 800-665-0411
Email: dvanzant@HomelandDefenseStocks.com, truehs@HomelandDefenseStocks.com






About the author:
BiodefenseStocks.com and HomelandDefenseStocks.com are investor and industry news portals for the biodefense and homeland security sector. The BS and HDS websites do not make recommendations, but offer unique free information portals to research news, exclusive articles, interviews, investor conferences and a growing list of participating public companies in these sectors.